Symbol="CNTX"
AssetType="Common Stock"
Name="Context Therapeutics Inc"
Description="Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts."
CIK="1842952"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="18520700"
EBITDA="-14871935"
PERatio="None"
PEGRatio="None"
BookValue="1.8"
DividendPerShare="0"
DividendYield="0"
EPS="-1.04"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.286"
ReturnOnEquityTTM="-0.478"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.04"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.319"
EVToRevenue="-"
EVToEBITDA="1.597"
Beta="None"
num_52WeekHigh="2.3"
num_52WeekLow="0.47"
num_50DayMovingAverage="1.122"
num_200DayMovingAverage="0.926"
SharesOutstanding="15966100"
DividendDate="None"
ExDividendDate="None"
symbol="CNTX"
open="1.19"
high="1.19"
low="1.14"
price="1.16"
volume="7800.00"
latest_trading_day="2023-07-21"
previous_close="1.19"
change="-0.03"
change_percent="-2.5210%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="138988"
Change_recent_avg="0.01"
Delta_recent_avg="0.09"
Variance_recent_avg="0.04"
Change_ratio_recent_avg="0.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="1138"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0171.jpeg"
image_negative_thumbnail_id_2="1126"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0159.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="590"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_positive_thumbnail_id_1="688"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0020.jpeg"
image_positive_thumbnail_id_2="607"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0101.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
